Literature DB >> 9148004

The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females.

C M van Nieuwerk1, A K Groen, R Ottenhoff, M van Wijland, M A van den Bergh Weerman, G N Tytgat, J J Offerhaus, R P Oude Elferink.   

Abstract

BACKGROUND/AIMS: The mouse mdr2 gene encodes a P-glycoprotein expressed in the canalicular membrane of the hepatocyte. Mice in which this gene has been inactivated (mdr2 -/-) show a defect in biliary phospholipid and cholesterol secretion and develop non-suppurative cholangitis. We hypothesized that secretion of bile salts without lipids initiates this liver disease.
METHODS: To delineate the pathologic process, mdr2 (-/-) mice were fed different bile salt-supplemented diets for 22 weeks after weaning. Aspects of liver pathology including eosinophilic bodies, portal inflammation, ductular proliferation, mitotic activity and fibrosis were semi-quantitatively scored.
RESULTS: It was observed that liver pathology was more severe in female than in male mice when fed a purified control diet. This correlated with a more hydrophobic bile salt composition of female vs. male bile. When increasing amounts of cholate were added to the diet (0.01% and 0.1%), the secretion of taurocholate increased and this was accompanied by a more severe liver pathology. At the high dose of cholate (0.1%), the bile salt compositions of male and female mice became similar, as did the severity of the histological score. Addition of cholate to the diet did not induce liver pathology in (+/+) mice. Addition of ursodeoxycholate to the diet (0.5%) led to a near complete replacement of biliary bile salts by tauroursodeoxycholate and this reduced pathology and dissipated the difference between males and females.
CONCLUSIONS: These observations support our hypothesis that liver pathology in the mdr2 (-/-) mouse is caused by bile salts and depends on the hydrophobicity c.q. cytotoxicity of biliary bile salts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148004     DOI: 10.1016/s0168-8278(97)80020-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  26 in total

1.  ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums.

Authors:  Jeannie Chan; Michael C Mahaney; Rampratap S Kushwaha; Jane F VandeBerg; John L VandeBerg
Journal:  J Lipid Res       Date:  2010-05-20       Impact factor: 5.922

2.  Mouse Models of Liver Fibrosis.

Authors:  Aashreya Ravichandra; Robert F Schwabe
Journal:  Methods Mol Biol       Date:  2021

3.  Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.

Authors:  Cindy Kunne; Marijke de Graaff; Suzanne Duijst; Dirk R de Waart; Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

4.  Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.

Authors:  Alexander G Miethke; Wujuan Zhang; Julia Simmons; Amy E Taylor; Tiffany Shi; Shiva Kumar Shanmukhappa; Rebekah Karns; Shana White; Anil G Jegga; Celine S Lages; Stephenson Nkinin; Bradley T Keller; Kenneth D R Setchell
Journal:  Hepatology       Date:  2015-08-21       Impact factor: 17.425

5.  The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.

Authors:  Xiaojiaoyang Li; Runping Liu; Jing Yang; Lixin Sun; Luyong Zhang; Zhenzhou Jiang; Puneet Puri; Emily C Gurley; Guanhua Lai; Yuping Tang; Zhiming Huang; William M Pandak; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2017-07-20       Impact factor: 17.425

6.  Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.

Authors:  Renxue Wang; Jonathan A Sheps; Lin Liu; Jun Han; Patrick S K Chen; Jason Lamontagne; Peter D Wilson; Ian Welch; Christoph H Borchers; Victor Ling
Journal:  J Lipid Res       Date:  2018-11-11       Impact factor: 5.922

7.  Modeling hepatic osteodystrophy in Abcb4 deficient mice.

Authors:  Katrin Hochrath; Sabrina Ehnert; Cheryl L Ackert-Bicknell; Yvonne Lau; Andrea Schmid; Marcin Krawczyk; Jan G Hengstler; Jordanne Dunn; Kanishka Hiththetiya; Birgit Rathkolb; Kateryna Micklich; Wolfgang Hans; Helmut Fuchs; Valérie Gailus-Durner; Eckhard Wolf; Martin Hrabě de Angelis; Steven Dooley; Beverly Paigen; Britt Wildemann; Frank Lammert; Andreas K Nüssler
Journal:  Bone       Date:  2013-03-29       Impact factor: 4.398

8.  ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.

Authors:  B L Vaisman; G Lambert; M Amar; C Joyce; T Ito; R D Shamburek; W J Cain; J Fruchart-Najib; E D Neufeld; A T Remaley; H B Brewer; S Santamarina-Fojo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 9.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

10.  Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.

Authors:  James H Tabibian; Slobodan I Macura; Steven P O'Hara; Jeff L Fidler; James F Glockner; Naoki Takahashi; Val J Lowe; Bradley J Kemp; Prasanna K Mishra; Pamela S Tietz; Patrick L Splinter; Christy E Trussoni; Nicholas F LaRusso
Journal:  Lab Invest       Date:  2013-04-15       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.